Recently published in The Journal of Translational Medicine, a team at Lawson Health Research Institute has discovered unique patterns of blood plasma proteins in patients with long COVID that could reveal potential drug targets to improve patient outcomes.
Ozempic 3.0? Lilly’s ‘triple-G’ drug shows biggest weight loss yet in mid-stage trial
SAN DIEGO — Ozempic and Wegovy became weight loss sensations by targeting a single hormone, leading people to lose as much as 15% of their